The cost of AstraZeneca’s new R&D hub and corporate headquarters in Cambridge has swelled to £750 million, more than twice the original estimate, says a report in The Times. The cost of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback